Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
The Oncologist|May 31, 2022
Management of Acral and Mucosal Melanoma: Medical Oncology PerspectiveSeungyeon Jung, Douglas B JohnsonThe Oncologist|June 20, 2023
Therapeutic Responses to Combination Nivolumab and Temozolomide as Salvage Therapy for Metastatic Melanoma: A Case SeriesRachel S Goodman, Seungyeon Jung, Jessica Quintos, et al.The Oncologist|October 26, 2022
Recurrence of Hypophysitis After Immune Checkpoint Inhibitor RechallengeBenjamin C Park, Seungyeon Jung, Jordan J Wright, et al.Immunological Reviews|July 20, 2023
Biomarkers of immune checkpoint inhibitor response and toxicity: Challenges and opportunitiesRachel S Goodman, Seungyeon Jung, Justin M Balko, et al.Journal of Drugs in Dermatology : JDD|June 5, 2023
Cross-Sectional Study of Psoriasis, Atopic Dermatitis, Rosacea, and Alopecia Areata Suggests Association With Cardiovascular DiseasesAngel D Pagan, Seungyeon Jung, Stella Caldas, et al.American Journal of Clinical Dermatology|June 16, 2022
Challenging Dermatologic Considerations Associated with Immune Checkpoint InhibitorsBenjamin C Park, Seungyeon Jung, Steven T Chen, et al.The Oncologist|August 5, 2023
Prognostic Risk Stratification and End-of-Life Care Outcomes in Patients With Metastatic Melanoma Treated With Immune Checkpoint InhibitorsRobert N Grad, Seungyeon Jung, Fei Ye, et al.American Journal of Clinical Dermatology|August 22, 2023
Alopecia Areata: Current Treatments and New DirectionsDante Dahabreh, Seungyeon Jung, Yael Renert-Yuval, et al.Cancers|July 13, 2024
Primary Tumor Characteristics as Biomarkers of Immunotherapy Response in Advanced Melanoma: A Retrospective Cohort StudyRachel S Goodman, Seungyeon Jung, Kylie Fletcher, et al.Nature Communications|July 10, 2018
Microtubule minus-end aster organization is driven by processive HSET-tubulin clustersStephen R Norris, Seungyeon Jung, Prashant Singh, et al.Pageof 2